-

Global Digital Patient Monitoring Devices Market Report 2021: Market to Surpass $200 Billion by 2027 - Wearable Devices to Account for $69.6 Billion - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Digital Patient Monitoring Devices - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Global Digital Patient Monitoring Devices Market to Reach $200.9 Billion by 2027

Amid the COVID-19 crisis, the global market for Digital Patient Monitoring Devices estimated at US$ 47.4 Billion in the year 2020, is projected to reach a revised size of US$ 200.9 Billion by 2027, growing at a CAGR of 22.9% over the analysis period 2020-2027.

Wearable Devices, one of the segments analyzed in the report, is projected to record a 23.9% CAGR and reach US$ 69.6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the mHealth segment is readjusted to a revised 26.6% CAGR for the next 7-year period.

The U.S. Market is Estimated at $12.8 Billion, While China is Forecast to Grow at 28.6% CAGR

The Digital Patient Monitoring Devices market in the U.S. is estimated at US$ 12.8 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$ 49.1 Billion by the year 2027 trailing a CAGR of 28.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 18% and 20.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 19.6% CAGR.

Wireless Sensor Technology Segment to Record 17.6% CAGR

In the global Wireless Sensor Technology segment, USA, Canada, Japan, China and Europe will drive the 16.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$ 7.9 Billion in the year 2020 will reach a projected size of US$ 23.5 Billion by the close of the analysis period.

China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$ 30.2 Billion by the year 2027, while Latin America will expand at a 18.9% CAGR through the analysis period.

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • Global Competitor Market Shares
  • Digital Patient Monitoring Devices Competitor Market Share Scenario Worldwide (in %): 2020E
  • Global Competitor Market Shares by Segment

2. FOCUS ON SELECT PLAYERS (Total 42 Featured):

  • Airstrip Technologies Inc.
  • AT&T INC.
  • Athena health Inc
  • Fitbit Inc.
  • Garmin Ltd.
  • GE Healthcare
  • Jawbone
  • Medtronic Plc
  • Omron Corporation
  • Phillips Healthcare
  • ResMed
  • VitalConnect
  • Welch Allyn
  • Zephyr Technology Corporation

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

  • UNITED STATES
  • Market Facts & Figures
  • Market Analytics
  • CANADA
  • JAPAN
  • CHINA
  • EUROPE
  • Market Facts & Figures
  • Market Analytics
  • FRANCE
  • GERMANY
  • ITALY
  • UNITED KINGDOM
  • SPAIN
  • RUSSIA
  • REST OF EUROPE
  • ASIA-PACIFIC
  • AUSTRALIA
  • INDIA
  • SOUTH KOREA
  • REST OF ASIA-PACIFIC
  • LATIN AMERICA
  • ARGENTINA
  • BRAZIL
  • MEXICO
  • REST OF LATIN AMERICA
  • MIDDLE EAST
  • IRAN
  • ISRAEL
  • SAUDI ARABIA
  • UNITED ARAB EMIRATES
  • REST OF MIDDLE EAST
  • AFRICA

IV. COMPETITION

  • Total Companies Profiled: 42

For more information about this report visit https://www.researchandmarkets.com/r/b88z1v

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Blockchain and Non-Fungible Tokens new Technologies and the Relevant Law Training Course: Core Principles, Smart Contracts, NFTs, and Decentralized Finance Explained (Online Event: May 20, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Blockchain and Non-Fungible Tokens: Understanding new Technologies and the Relevant Law Training Course (May 20, 2026)" training has been added to ResearchAndMarkets.com's offering. Blockchain is a new technology that could potentially have major impacts in a wide range of industries. It has the potential to dramatically change how business is conducted - but there is no one central authority controlling blockchain, everyone has access to the same information. Are...

Writing Clinical Research with Integrity Training Course: Principles of Medical and Scientific Writing, Including Ethical Standards, Data Integrity, and Plagiarism Prevention (Online: Apr 20, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Writing Clinical Research with Integrity Training Course (Apr 20, 2026)" training has been added to ResearchAndMarkets.com's offering. This course covers key principles of medical and scientific writing, including ethical standards, data integrity, and plagiarism prevention. Participants will learn how to tailor content for various audiences, structure documents (e.g., manuscripts, protocols), and adhere to writing standards such as clarity, consistency, and correc...

In-Vitro Diagnostic Regulation (EU) 2017/746 Introduction Training Course (Online Event: Apr 16th - Apr 17th, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Introduction to the In-Vitro Diagnostic Regulation (IVDR) Training Course (Apr 16th - Apr 17th, 2026)" training has been added to ResearchAndMarkets.com's offering. The In-Vitro Diagnostic Regulation (EU) 2017/746, which came into force in May 2017 with a transition period of five years, is intended to strengthen the current approval system for in-vitro diagnostics and makes substantial changes to the existing IVD Directive (98/79/EC) legislation. The Regulation in...
Back to Newsroom